Biogen Slashes Price of Alzheimer’s Drug Aduhelm, as It Faces Obstacles
Sam Gandy, MD, PhD, comments on Alzheimer's drug, aduhelm. Gandy said that with advocacy groups like the Alzheimer’s Association still supporting the drug’s approval, he had a “concern that calling for something may trigger a backlash that undoes where we really want to go.”
Press Release
Researchers Identify the Role of an Alzheimer’s Disease Risk Gene in the Brain
Nov 30, 2022 View All Press Releases